N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N’-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate | |
---|---|
Trade Name | |
Orphan Indication | Renal cancer |
EU Market Approval | EU |
EU Designation Date | 2010-06-09 00:00:00 |
Sponsor | EUSA Pharma (UK) Limited |